Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FU.4ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
FU.4ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
FU.4ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FU.4ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FU.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FU.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FU.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
FU.4ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-17292.3China
FU.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
FU.4ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
FU.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FU.4SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
FU.4SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
FU.4SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
FU.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FU.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-18758.6South Korea
FU.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FU.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
FU.4NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
FU.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FU.4NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
FU.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FU.4NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
FU.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FU.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FU.4NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
FU.4NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
FU.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FU.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FU.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FU.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FU.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FU.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FU.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FU.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
FU.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FU.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FU.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.4NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FU.4ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
FU.4ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-25657.5Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used